Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals
- PMID: 15010286
- DOI: 10.1016/j.yexmp.2003.12.002
Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals
Abstract
Killer-inhibitory receptors (KIR) are receptors for self-HLA class I molecules, which are expressed on natural killer (NK) cells and small subsets of T-lymphocytes. KIR receptors that do not bind to self-HLA class I have been implicated in the pathogenesis of pure red-cell aplasia and other autoimmune diseases. However, NK cells whose inhibitory receptors lack any apparent self-ligand can also be found in healthy individuals. We therefore tested whether these NK cells are capable of exerting cytotoxic activity against autologous CD34(+) hematopoietic precursors. We detected NK cells whose sole inhibitory receptors were CD94/NKG2-A and that had no affinity for autologous HLA-C molecules. In vitro, such cells were able to kill autologous CD34(+) stem cells that expressed MHC class I antigen at a high level in about 50% of the cases of HLA-C group 2 donors. Two individual clones derived from this NK subpopulation were stimulated by autologous HLA-Cw5/6-positive stem cells, but not by allogeneic HLA-Cw7-positive stem cells. Our findings demonstrate the presence of potentially autoreactive natural killer cells in otherwise healthy individuals.
Similar articles
-
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.Eur J Immunol. 2003 Jun;33(6):1657-66. doi: 10.1002/eji.200323986. Eur J Immunol. 2003. PMID: 12778484
-
Natural killer cell recognition of HLA class I molecules.Rev Immunogenet. 2000;2(3):433-48. Rev Immunogenet. 2000. PMID: 11256749 Review.
-
Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.J Immunol. 1999 May 15;162(10):5902-9. J Immunol. 1999. PMID: 10229826
-
Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.J Immunol. 1998 Jun 1;160(11):5239-45. J Immunol. 1998. PMID: 9605119
-
Killer immunoglobulin-like receptors.Curr Opin Immunol. 2004 Oct;16(5):626-33. doi: 10.1016/j.coi.2004.07.010. Curr Opin Immunol. 2004. PMID: 15342010 Review.
Cited by
-
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.Blood. 2005 Jun 15;105(12):4878-84. doi: 10.1182/blood-2004-12-4825. Epub 2005 Feb 24. Blood. 2005. PMID: 15731175 Free PMC article.
-
Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIR.Front Immunol. 2016 Aug 24;7:299. doi: 10.3389/fimmu.2016.00299. eCollection 2016. Front Immunol. 2016. PMID: 27605928 Free PMC article.
-
Cancer treatment and the KIR-HLA system: an overview.Clin Exp Med. 2017 Nov;17(4):419-429. doi: 10.1007/s10238-017-0455-4. Epub 2017 Feb 10. Clin Exp Med. 2017. PMID: 28188495 Review.
-
Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma.Br J Cancer. 2007 Aug 20;97(4):539-42. doi: 10.1038/sj.bjc.6603913. Epub 2007 Jul 31. Br J Cancer. 2007. PMID: 17667923 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials